The debate over the use and safety of vaccinations has been raging on for decades but for any one who questions the safety and efficacy of vaccines, they have often been stifled and labelled as unscientific and their information not evidence based. HPV Vaccination was introduced in 2006 by Merck+Co as a vaccine to fight cervical cancer. We want to look at the evidence backing its use and the safety profile that the vaccine presents in the literature.
Their claim is Gardasil9 “will protect against approximately 90% of cervical cancers”, and the American Cancer Society recommends HPV vaccination for girls ages 11 to 12, although girls as young as 9 may receive the vaccine, and it’s also recommended for girls ages 13 to 18 in order to catch up on missed vaccines or complete the series.
Since 2006, the HPV vaccine (marketed as Gardasil by Merck+Co and Cervarix by GSK), it has been introduced in to the National Immunisation Schedule to over 41% of countries as of May 2018 [WHO], and Merck+Co alone has made over $18USD Billion in sales revenue since its introduction.
What is HPV:
HPV is short for Human Papilloma Virus, a common virus with an estimated 80% of women who have it and in 90% of cases it is harmless. Most cases of HPV do not progress to genital warts or cervical cancers. HPV is not the sole cause of cervical cancer, but a factor, with other co-factors needed in order for cervical cancer to develop. There are 20 strains of HPV known to cause cancer (>100 types of HPV) and 15 strains are considered high risk. Pap smear screening is effective in determining early onset of cancer and intervention, however, improved environmental factors and education reduced disease rates prior to screening test.
1.The evidence to support the use of hpv vaccine does not exist for the end cause desired – reduction in cervical cancer cases.
2.Risks are greater than benefits – and the statement that the use of vaccine and any risk associated with it is better than the disease itself is unfounded.
The video will demonstrate that there is no evidence that the vaccine will prevent any cancer and has not been proven to prevent a single death from cervical cancer. Furthermore, it has not been tested through trials in the age group it is recommended for, not has the end target result been actually examined – the prevention of Cervical Cancer! Furthermore, the demand for such a vaccine was never in place until such time that the demand was created by those who benefit from the sales the most!
When the evidence is so lacking, a single potential risk is an infinitely too high a risk to take… let alone the fact that the HPV vaccine has had three times rate of “reported” adverse reactions after HPV vaccine than all other vaccines combined to the CDC. That is only those adverse drug reactions that have been reported and only limited to the USA! Serious adverse drug reactions include Paralysis, seizures, MS, blood clotting, stroke, heart attack, nerve damage, death, and life time infertility and more…
The risk of a serious adverse drug reactions is estimated to be 1 in 500 – while the risk of cervical cancer is estimated at 1 in 40,000.
The numbers simply do not add up!
- Vaccine only protects from 2-9 of the 15 high risk hpv variants. (PI)
- Hpv is not an independent cause of cervical cancer.
- HPV is common (80%), and in most cases (90%), warts or cancer do not develop.
- Cervical cancer is treatable if it ever develops (3.7% of new cancers). Prognosis is good.
- Not a major cause of death! There was never a need, Demand was created for such a vaccine.
- Note: Not effective if some one is already infected (a large population!). Not effective against other strains that may lead to cervical cancer. (PI)
- Approval for use was fast tracked outside the normal guidelines.
- Risk to Benefit is very high.
- Mandating such a vaccine is not only unethical, but lacking in evidence.
- Parents should make an informed decision.
- The claim made by manufacturers that it helps prevent Cervical Cancer must be questioned.